Asset Management One
ADMS

Asset Management One’s Adamas Pharmaceuticals ADMS Stock Holding History

Asset Management One’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,494
Closed -$326K – 1360
2015
Q4 		$326K Sell
11,494
-7,540
-40% -$127K ﹤0.01% 1143
2015
Q3 		$319K Hold
19,034
– – ﹤0.01% 1153
2015
Q2 		$499K Hold
19,034
– – 0.01% 1100
2015
Q1 		$333K Buy
+19,034
New +$326K ﹤0.01% 1175

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Asset Management One's ADMS Position: Q1 2016 in Review

Asset Management One sold out of Adamas Pharmaceuticals (ADMS) in Q1 2016, closing a stake of 11,494 shares — an estimated $326K sold.

Asset Management One first reported a position in ADMS in Q1 2015 and held it in 4 quarters. The position peaked at $499K in Q2 2015. 84 funds tracked by Wall St. Rank hold ADMS as of Q1 2016.

  • Asset Management One reported no remaining Adamas Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Asset Management One sold 11,494 Adamas Pharmaceuticals shares in Q1 2016, an estimated $326K.
  • Asset Management One first reported a position in Adamas Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Asset Management One's Adamas Pharmaceuticals position peaked at $499K in Q2 2015.
  • 84 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2016.

Based on Asset Management One's 13F filing for Q1 2016, filed 5 May 2016.